D. Neto

The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

C. Turesson, P. V. van Riel, X. Mariette, 2015, RMD Open.

Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial

P. Guerne, D. Kyburz, A. Finckh, 2014, Arthritis Research & Therapy.

FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries

Helena Canhão, Xavier Mariette, C. Turesson, 2014 .

Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK

T. Huizinga, L. Sawyer, A. Finckh, 2014, PharmacoEconomics.

FRI0322 Positivity for Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide is Associated with A Better Drug Retention of Abatacept: Data from A Paneuropean Analysis of RA Registries

C. Turesson, X. Mariette, K. Pavelka, 2014 .